China NMPA Product Recall - Single-photon emission and X-ray computed tomography (SPECT) system; Single-photon emission computed tomography (SPECT) scanning system; Forte gamma camera system; Single-photon emission and X-ray computed tomography (SPECT) imaging system
China NMPA product recall for Single-photon emission and X-ray computed tomography (SPECT) system; Single-photon emission computed tomography (SPECT) scanning system; Forte gamma camera system; Single-photon emission and X-ray computed tomography (SPECT) imaging system by Philips (China) Investment Co., Ltd. published January 28, 2021. Recall level: Level 2. Philips (China) Investment Co., Ltd. initiated a voluntary Level II recall for several models of its
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Single-photon emission and X-ray computed tomography (SPECT) system; Single-photon emission computed tomography (SPECT) scanning system; Forte gamma camera system; Single-photon emission and X-ray computed tomography (SPECT) imaging system by Philips (China) Investment Co., Ltd. published January 28, 2021. Recall level: Level 2. Philips (China) Investment Co., Ltd. initiated a voluntary Level II recall for several models of its
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox